Trial document



drksid header

  DRKS00007899

Trial Description

start of 1:1-Block title

Title

The effects of repetitive peripheral magnetic stimulation in patient with spastic hemiparesis after stroke: A randomized-controlled study

end of 1:1-Block title
start of 1:1-Block acronym

Trial Acronym

[---]*

end of 1:1-Block acronym
start of 1:1-Block url

URL of the Trial

[---]*

end of 1:1-Block url
start of 1:1-Block public summary

Brief Summary in Lay Language

In this study, the effectiveness of repetitive peripheral magnet stimulation (rPMS) is compared to peripheral electrical stimulation.
rPMS improves the functional status of a paretic hand/arm and spasticity after stroke. Since now it is unclear how effective rPMS is.
Patients were randomly assigned to “magnetic stimulation group” or “electrical stimulation group.
The stimulation is applied every day from monday to friday for 3 weeks. In regular intervals assessments were performed for the function of the upper limb and mobility to find out how effective rPMS is.
We hypothesized that rPMS is the more effective stimulation method to improve lost functions in the affected upper limb and the activities of daily living.

end of 1:1-Block public summary
start of 1:1-Block scientific synopsis

Brief Summary in Scientific Language

Repetitive peripheral magnetic stimulation (rPMS) is a stimulation method with strong and rapidly changed magnetic fields that's applicated on a muscle to produce repetitive muscle contractions.
The first rPMS trials by patients after stroke were performed in the 90s by the research group by Albrecht Struppler. These first trials indicated an improvement of voluntary activity, spasticity and perception after rPMS.
In this randomized-controlled trial the effect of rPMS will be examined in patients after stroke. The patients are randomly assigned in the intervention group(magnetic stimulation) and the control group (electrical stimulation). The intervention /controllintervention be applied daily (mon-fri) over three weeks.
To investigate the short- and long-term effects standardized the assessments will be evaluated at different times.

end of 1:1-Block scientific synopsis
start of 1:1-Block organizational data

Organizational Data

  •   DRKS00007899
  •   2015/03/24
  •   [---]*
  •   yes
  •   Approved
  •   4147-07/14, Ethikkommission der Friedrich-Schiller-Universität Jena an der Medizinischen Fakultät
end of 1:1-Block organizational data
start of 1:n-Block secondary IDs

Secondary IDs

  • [---]*
end of 1:n-Block secondary IDs
start of 1:N-Block indications

Health Condition or Problem studied

  •   I60-I69 -  Cerebrovascular diseases
  •   G81.1 -  Spastic hemiplegia
end of 1:N-Block indications
start of 1:N-Block interventions

Interventions/Observational Groups

  •   repetitive peripheral magnetic stimulation (rPMS) (interventiongroup):

    The stimulation is 15 minutes daily for three weeks with a total of 15 sessions.
    The stimulation intensity is adjusted individually for each patient, so that a joint movement resulting from the muscle contraction.

    Muscles of the upper arm and forearm are stimulated with a butterfly coil;
    The patient takes a sitting position with raised feet in the wheelchair or on a chair with backrest;
    The arm is placed to be stimulated or maintained by the therapist


    magnetic stimulator: Magstim Rapid²

    Instruction:
    Patients are asked to relax and observe their arm
  •   peripheral electrical stimulation (controlgroup):

    The stimulation is 15 minutes daily for three weeks with a total of 15 sessions.
    The stimulation intensity is adjusted individually for each patient, so that a joint movement resulting from the muscle contraction.

    Muscles of the upper arm and forearm are stimulated with electrodes;
    The patient takes a sitting position with raised feet in the wheelchair or on a chair with backrest;
    The arm is placed to be stimulated or maintained by the therapist;

    Electrical device: wellcare digi stim

    Instruction: Patients are asked to relax and observe their arm
end of 1:N-Block interventions
start of 1:1-Block design

Characteristics

  •   Interventional
  •   [---]*
  •   Randomized controlled trial
  •   Blinded
  •   assessor
  •   Active control (effective treament of control group)
  •   Treatment
  •   Parallel
  •   N/A
  •   N/A
end of 1:1-Block design
start of 1:1-Block primary endpoint

Primary Outcome

The primary outcome is the Fugl-Meyer Test of the upper extremity, a test that evaluated the function of the affected upper extremity. This test will be performed directly after the end of the three weeks intervention-/controllintervention.

end of 1:1-Block primary endpoint
start of 1:1-Block secondary endpoint

Secondary Outcome

The secondary outcome is determined with a questionnaire, the Katz Index of Independence Activities of daily living (ADL). That questionnaire aims to identify the dependence in the performance in the activities of daily living and will be performed six months after the end of the intervention /controllintervention.

end of 1:1-Block secondary endpoint
start of 1:n-Block recruitment countries

Countries of Recruitment

  •   Germany
end of 1:n-Block recruitment countries
start of 1:n-Block recruitment locations

Locations of Recruitment

  • Medical Center 
end of 1:n-Block recruitment locations
start of 1:1-Block recruitment

Recruitment

  •   Actual
  •   2015/04/15
  •   80
  •   Monocenter trial
  •   National
end of 1:1-Block recruitment
start of 1:1-Block inclusion criteria

Inclusion Criteria

  •   Both, male and female
  •   no minimum age
  •   no maximum age
end of 1:1-Block inclusion criteria
start of 1:1-Block inclusion criteria add

Additional Inclusion Criteria

subacute stroke (incident not longer than six months back)
spastic hemiparesis of the upper limb (at least modified ashworth scale 1)
a slight function in the fingers or hand (at least 1 point in the Fugl-Meyer-test in subscore C)

end of 1:1-Block inclusion criteria add
start of 1:1-Block exclusion criteria

Exclusion Criteria

Epilepsy,
implantated metal in the stimulation area
implantated medical devices
dysfunctional speech comprehension
pregnancy

end of 1:1-Block exclusion criteria
start of 1:n-Block addresses

Addresses

  • start of 1:1-Block address primary-sponsor
    • Moritz Klinik Bad Klosterlausnitz
    • Hermann-Sachse-Straße 46
    • 07639  Bad Klosterlausnitz
    • Germany
    end of 1:1-Block address primary-sponsor
    start of 1:1-Block address contact primary-sponsor
    •   [---]*
    •   [---]*
    •   [---]*
    •   [---]*
    end of 1:1-Block address contact primary-sponsor
  • start of 1:1-Block address scientific-contact
    • Moritz Klinik Bad Klosterlausnitz
    • Ms.  Kristin  Pohl 
    • Hermann-Sachse-Straße 46
    • 07639  Bad Klosterlausnitz
    • Germany
    end of 1:1-Block address scientific-contact
    start of 1:1-Block address contact scientific-contact
    end of 1:1-Block address contact scientific-contact
  • start of 1:1-Block address public-contact
    • Moritz Klinik Bad Klosterlausnitz
    • Ms.  Kristin  Pohl 
    • Hermann-Sachse-Straße 46
    • 07639  Bad Klosterlausnitz
    • Germany
    end of 1:1-Block address public-contact
    start of 1:1-Block address contact public-contact
    end of 1:1-Block address contact public-contact
end of 1:n-Block addresses
start of 1:n-Block material support

Sources of Monetary or Material Support

  • start of 1:1-Block address materialSupport
    • Moritz Klinik GmbH & Co.KG
    • Hermann-Sachse-Straße 46
    • 07639  Bad Klosterlausnitz
    • Germany
    end of 1:1-Block address materialSupport
    start of 1:1-Block address contact materialSupport
    end of 1:1-Block address contact materialSupport
end of 1:n-Block material support
start of 1:1-Block state

Status

  •   Recruiting ongoing
  •   [---]*
end of 1:1-Block state
start of 1:n-Block publications

Trial Publications, Results and other Documents

  • [---]*
end of 1:n-Block publications
* This entry means the parameter is not applicable or has not been set.